M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation

Europace

Volumn 17, Issue 2, 2014, Pages 239-246

  Gurses, Kadri Murat ^a   Yalcin, Muhammed Ulvi ^a   Kocyigit, Duygu ^a   Kesikli, Sacit Altug ^a   Canpolat, Ugur ^b   Yorgun, Hikmet ^a   Sahiner, Mehmet Levent ^a   Kaya, Ergun Baris ^a   Hazirolan, Tuncay ^a   Ozer, Necla ^a   Oto, Mehmet Ali ^a   Guc, Dicle ^a   Aytemir, Kudret ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Ankara Yuksek Ihtisas Education and Research Hospital   (Turkey)

Author keywords

Atrial fibrillation; Atrial fibrosis; Cryoablation; M2 muscarinic receptor autoantibodies

Indexed keywords

AUTOANTIBODY; M2 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; MUSCARINIC M2 RECEPTOR;

ABLATION THERAPY; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOABLATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM FIBROSIS; HEART MUSCLE FIBROSIS; HUMAN; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; ATRIAL FIBRILLATION; CASE CONTROL STUDY; CRYOSURGERY; FIBROSIS; HEART ATRIUM; HEART MUSCLE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX;

ATRIAL FIBRILLATION; AUTOANTIBODIES; CASE-CONTROL STUDIES; CRYOSURGERY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HEART ATRIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PROPORTIONAL HAZARDS MODELS; RECEPTOR, MUSCARINIC M2; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 84922465109     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu228     Document Type: Article

References (21)

1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
2. Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, et al. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 2004;25: 1108-15.
3. Stavrakis S, Yu X, Patterson E, Huang S, Hamlett SR, Chalmers L, et al. Activating autoantibodies to the beta-1 adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J Am Coll Cardiol 2009;54: 1309-16.
4. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92: 1954-68.
5. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005;293:2634-40.
6. Oto A, Aytemir K, Canpolat U, Karakulak U, Evranos B, Sahiner L, et al. [Pulmonary vein isolation with the cryoballoon technique in atrial fibrillation treatment: single centre experience]. Turk Kardiyol Dern Ars 2013;41:299-309.
7. Neumann T, Wojcik M, Berkowitsch A, Erkapic D, Zaltsberg S, GreissH et al. Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcomeafter single procedure and predictors of success. Europace 2013;15:1143-9.
8. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119: 1758-67.
9. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol 2011;22:16-22.
10. Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, et al. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001;103: 1765-71.
11. Zou C, Zhang Z, Zhao W, Li G, Ma G, Yang X, et al. Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablation. J Transl Med 2013;11:7.
12. Hong CM, Zheng QS, Liu XT, Shang FJ, Wang HT, Jiang WR. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo. Cardiology 2009; 112:180-7.
13. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/ EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
14. Hsu LY, Ingkanisorn WP, Kellman P, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. Part II: clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23:309-14.
15. Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CTet al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm 2010;7:1475-81.
16. Everett TH, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007;4:S24-7.
17. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 2011;58:2225-32.
18. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, et al. Preexistent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 2005;45:285-92.
19. den Uijl DW, Delgado V, Bertini M, Tops LF, Trines SA, van de VeireNR et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 2011;97:1847-51.
20. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 2014;311:498-506.
21. Vatner DE, Sato N, Galper JB, Vatner SF. Physiological and biochemical evidence for coordinate increases in muscarinic receptors and Gi during pacing-induced heart failure. Circulation 1996;94:102-7.